Journal of Surgical Research
Volume 152, Issue 1 , Pages 26-34 , March 2009

TGF-β1 and IGF-1 Production and Recurrence of Crohn's Disease After Ileo-Colonic Resection

Presented as oral presentation at the Digestive Disease Week, Washington, DC, May 19–24, 2007 and, as a poster, at the ECCO-IBD Congress, Innsbruck, Austria March 1–3,2007.

  • Marco Scarpa, M.D.

      Affiliations

    • Clinica Chirurgica I, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Padova, Padova, Italy
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Clinica Chirurgica I, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, Policlinico Universitario, Università di Padova, via Giustiniani 2, 35128 Padova, Italy
    • ,
  • Marina Bortolami, B.Sc.

      Affiliations

    • Gastroenterologia, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Padova, Padova, Italy
    • ,
  • Susan L. Morgan, M.D.

      Affiliations

    • Department of Pathology, Institute for Cancer Studies, Birmingham Medical School, University of Birmingham, Birmingham, United Kingdom
    • ,
  • Andromachi Kotsafti, B.Sc.

      Affiliations

    • Gastroenterologia, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Padova, Padova, Italy
    • ,
  • Stefania Ferraro, M.D.

      Affiliations

    • Clinica Chirurgica I, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Padova, Padova, Italy
    • ,
  • Cesare Ruffolo, M.D.

      Affiliations

    • Clinica Chirurgica I, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Padova, Padova, Italy
    • ,
  • Renata D'Incà, M.D.

      Affiliations

    • Gastroenterologia, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Padova, Padova, Italy
    • ,
  • Lino Polese, M.D.

      Affiliations

    • Clinica Chirurgica I, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Padova, Padova, Italy
    • ,
  • Michela Barollo, M.D.

      Affiliations

    • Gastroenterologia, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Padova, Padova, Italy
    • ,
  • Davide F. D'Amico, M.D.

      Affiliations

    • Clinica Chirurgica I, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Padova, Padova, Italy
    • ,
  • Giacomo C. Sturniolo, M.D.

      Affiliations

    • Gastroenterologia, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Padova, Padova, Italy
    • ,
  • Imerio Angriman, M.D.

      Affiliations

    • Clinica Chirurgica I, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Padova, Padova, Italy

Received 16 June 2007

References 

  1. Williams JG, Wong WD, Rothenberger DA, et al. Recurrence of Crohn's disease after resection. Br J Surg. 1991;78:10
  2. Tytgat GNJ, Mulder GJI, Brummerlkamp WH. Endoscopic lesion in Crohn's disease early after ileocecal resection. Endoscopy. 1988;20:260
  3. Yamamoto T. Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol. 2005;11:3971
  4. Van Assche G, Geboes K, Rutgeerts P. Medical therapy for Crohn's disease strictures. Inflamm Bowel Dis. 2004;10:55
  5. Pucilowska JB, Wiiliams KL, Lund PK. Fibrosis and inflammatory bowel disease: Cellular mediators and animal models. Am J Physiol Gastrointest Liver Physiol. 2000;279:G653
  6. Koukoulis G, Ke Y, Henley JD, et al. Obliterative muscularization of the small bowel submucosa in Crohn disease. Arch Pathol Lab Med. 2001;125:1331
  7. Simmons JG, Pucilowska JB, Keku TK, et al. IGF-1 and TGF have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiol Gastrointest Liver Physiol. 2002;283:G809
  8. Regan MC, Flavin BM, Fitzpatrick JM, et al. Stricture formation in Crohn's disease (The role of intestinal fibroblasts). Ann Surg. 2000;231:46
  9. Del Zotto B, Mumolo G, Pronio AM, et al. TGF-β1 production in inflammatory bowel disease: Differing production patterns in Crohn's disease and ulcerative colitis. Clin Exp Immunol. 2003;134:120
  10. McKaig BC, Hughes K, Tighe PJ, et al. Differential expression of TGF-b isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. Am J Physiol Cell Physiol. 2002;282:C172
  11. Massague J. Transforming growth factor beta. Annu Rev Cell Biol. 1990;6:597
  12. Walia B, Wang L, Merlin D. Sitaraman TGF-beta down-regulates IL-6 signalling in intestinal epithelial cells: critical role of SMAD-2. FASEB J. 2003;17:2130
  13. Kitani A, Fuss IJ, Nakamura K, et al. Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid. J Exp Med. 2000;192:41
  14. Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology. 1996;110:975
  15. Kader HA, Tchernev VT, Satyaraj E, et al. Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF (IL-7, TGF-β1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease). Am J Gastroenterol. 2005;100:414
  16. Hart AL, Kamm MA, Knight SC, et al. Quantitative and functional characteristics of intestinal-homing memory T cells: analysis of Crohn's disease patients and healthy controls. Clin Exp Immunol. 2004;135:137
  17. Stallmach A, Schuppan D, Riese HH, et al. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease. Gastroenterology. 1992;102:1920
  18. Theiss AL, Fruchtman S, Lund PK. Growth factors in inflammatory bowel disease the actions and interactions of growth hormone and insulin-like growth factor-I. Inflamm Bowel Dis. 2004;10:871
  19. El Yafi F, Winkler R, Delvenne P, et al. Altered expression of type I insulin-like growth factor receptor in Crohn's disease. Clin Exp Immunol. 2005;139:526
  20. Pucilowska JB, McNaughton KK, Mohapatra NK, et al. IGF-I and procollagen a1(I) are coexpressed in a subset of mesenchymal cells in active Crohn's disease. Am J Physiol Gastrointest Liver Physiol. 2000;279:G1307
  21. Zimmermann EM, Li L, Hou YT, et al. Insulin-like growth factor I and insulin-like growth factor binding protein 5 in Crohn's disease. Am J Physiol Gastrointest Liver Physiol. 2001;280:G1022
  22. Gilligham MB, Kritsch KR, Murali SG, et al. Resection upregulates the IGF-I system of parenterally fed rats with jejunocolic anastomosis. Am J Physiol Gastrointest Liver Physiol. 2001;281:G1158
  23. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet. 1980;1:514
  24. Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol. 2003;98:1309
  25. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156
  26. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity (Assessment of inflammation in rat and hamster models). Gastroenterology. 1984;87:1344
  27. Kristjansson G, Venge P, Wanders A, et al. Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: Studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome. Gut. 2004;53:1806
  28. Fazio VW, Marchetti F, Church M, et al. Effect of resection margins on the recurrence of Crohn's disease in the small bowel: A randomized controlled trial. Ann Surg. 1996;224:563
  29. Kanazawa S, Tsunoda T, Onuma E, et al. VEGF, basic-FGF, and TGF-β in Crohn's disease and ulcerative colitis: A novel mechanism of chronic intestinal inflammation. Am J Gastroenterol. 2001;96:822
  30. Di Mola FF, Friess H, Scheuren A, et al. Transforming Growth Factor-βs and their signaling receptors are coexpressed in Crohn's Disease. Ann Surg. 1999;229:67
  31. Mulsow JJW, Watson WRG, Fitzpatrick JM, O'Connell PR. transforming growth factor-β promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling. Ann Surg. 2005;242:880
  32. Monteleone G, Del Vecchio Blanco G, Monteleone I, et al. Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. Gastroenterology. 2005;129:1420
  33. Monteleone G, Mann J, Monteleone I, et al. A failure of Transforming Growth Factor-β1 negative regulation maintains sustained NF-κB activation in gut inflammation. J Biol Chem. 2004;279:3925
  34. Egan LJ, Sandborn WJ. Advances in the treatment of Crohn's disease. Gastroenterology. 2004;126:1574
  35. Street ME, De'Angelis G, Camacho-Hubner C, et al. Relationships between serum IGF-1, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease. Horm Res. 2004;61:159
  36. Williams KL, Fuller CR, Fagin J, et al. Mesenchymal IGF-I overexpression: paracrine effects in the intestine, distinct from endocrine actions. Am J Physiol Gastrointest Liver Physiol. 2002;283:G875
  37. Heimann TM, Greenstein AJ, Lewis B, et al. Comparison of primary and re-operative surgery in patients with Crohn's disease. Ann Surg. 1998;227:492

PII: S0022-4804(08)00301-6

doi: 10.1016/j.jss.2008.04.014

Journal of Surgical Research
Volume 152, Issue 1 , Pages 26-34 , March 2009

Article Tools

* Image Usage & Resolution